CIR Plans Re-Review Of Ingredient Safety Assessments
This article was originally published in The Rose Sheet
Executive Summary
The Cosmetic Ingredient Review panel voted to establish a mechanism for re-reviewing safety assessments during its Sept. 11 meeting in Washington D.C.
You may also be interested in...
CIR "Insufficient Data" Ingredients Subject Of Upcoming FDA Warning Letters
FDA is establishing a system to send warning letters to manufacturers using ingredients the Cosmetic Ingredient Review panel has determined do not have sufficient data to establish safety.
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program